Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Mesalazine for intestinal mucosal inflammation in acute pancreatitis
ChiCTR-IPR-15006398Phase 4Recruiting
- Sponsor
- West China Hospital of Sichuan University
- Start
- May 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of Salcrozine in acute pancreatitis (AP) (2 arms), sponsored by West China Hospital of Sichuan University. Primary endpoint: Intestinal mucosal inflammation scoring. Started May 2015; status: recruiting.
02
Drugs
Salcrozine
03
Conditions
acute pancreatitis (AP)
Beyond the preview
Go deeper on ChiCTR-IPR-15006398.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR-IPR-15006398.